Cellectar biosciences, inc. (CLRB)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

7,092

10,614

13,301

16,849

10,488

13,255

16,373

4,180

6,820

10,006

5,662

8,313

11,238

11,444

5,645

7,922

1,908

3,857

2,472

4,833

7,029

9,422

11,576

1,626

3,807

2,418

5,110

5,828

7,862

4,677

5,597

7,146

3,787

5,505

1,590

3,313

673

Restricted cash

-

-

0

0

0

55

55

55

55

55

55

55

55

55

55

55

55

55

55

55

55

55

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

55

55

55

55

55

55

55

-

-

-

55

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

55

55

55

-

55

55

555

Prepaid expenses and other current assets

771

770

1,450

1,333

604

641

685

780

770

412

970

969

893

693

437

162

281

267

445

118

171

220

290

334

212

294

329

147

191

327

335

138

183

254

303

53

51

Deferred financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

70

-

-

-

0

-

-

-

Deferred issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

159

57

-

Total current assets

7,863

11,385

14,751

18,183

11,092

13,951

17,114

5,016

7,645

10,473

6,687

9,337

12,186

12,193

6,138

8,139

2,244

4,180

2,972

5,006

7,255

9,698

11,921

2,016

4,075

2,768

5,494

6,030

8,109

5,130

5,988

7,340

4,025

5,815

2,108

3,479

1,279

RESTRICTED CASH

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,878

1,878

2,000

-

-

-

0

-

-

-

Fixed assets, net

411

435

461

492

516

543

191

211

228

244

1,496

1,576

1,423

1,444

1,464

1,551

1,637

1,728

1,801

1,886

1,968

2,033

2,111

2,185

2,277

2,360

2,449

2,513

2,621

2,645

2,697

2,807

2,919

3,044

3,183

3,249

3,510

Right-of-use asset, net

333

348

363

378

392

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

-

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

1,675

-

Long-term assets

81

75

75

75

540

540

540

-

-

465

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

0

6

6

6

6

18

18

93

11

11

11

11

11

11

17

11

11

11

11

11

11

11

11

12

11

11

27

27

27

27

27

27

27

27

27

27

11

TOTAL ASSETS

8,689

12,250

15,658

19,135

12,548

15,054

19,540

6,996

9,561

12,871

9,871

12,601

15,297

15,324

9,296

11,377

5,569

7,596

6,461

8,580

10,911

13,419

15,719

5,888

8,040

6,815

9,647

12,125

14,311

11,478

10,389

11,850

8,648

10,563

6,994

8,431

4,802

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Current maturities of notes payable

-

-

-

-

-

-

-

-

-

-

0

0

0

86

147

208

244

243

242

240

180

119

103

41

-

0

-

-

-

-

-

-

-

-

-

-

204

Accounts payable and accrued liabilities

2,941

2,663

2,875

2,528

2,055

1,543

2,571

2,093

1,883

1,867

2,019

1,466

1,186

1,416

1,087

816

608

675

579

712

824

933

1,139

1,195

992

1,162

1,157

1,021

862

716

712

607

471

478

441

365

392

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

305

Derivative liability

-

-

0

46

47

43

86

152

132

105

110

119

209

127

187

365

1,956

4,781

4,651

4,884

4,888

5,176

4,093

2,840

3,414

3,359

3,469

5,066

5,727

13

21

25

32

23

77

81

-

Capital lease obligations, current portion

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease obligations, current portion

-

-

-

0

1

2

3

3

3

3

2

2

2

2

2

2

2

2

2

2

2

2

2

0

1

1

2

2

2

2

2

2

2

2

2

2

2

Deferred rent

-

-

0

0

0

33

0

40

88

138

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liability

109

105

102

99

96

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

3,050

2,769

2,977

2,673

2,199

1,622

2,660

2,289

2,107

2,114

2,132

1,588

1,398

1,632

1,425

1,393

2,812

5,703

5,475

5,839

5,895

6,233

5,338

4,077

4,407

4,523

4,629

6,090

6,592

732

736

635

506

503

521

449

904

LONG-TERM LIABILITIES:
Capital lease obligation, less current portion

-

-

-

-

-

-

0

0

1

2

3

3

4

5

5

6

7

7

8

9

9

11

11

-

-

0

0

0

1

1

2

2

3

4

4

5

6

Convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,796

3,765

-

-

-

-

-

-

-

-

-

-

-

2,720

Notes payable, less current maturities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

24

86

147

208

269

330

346

408

450

450

450

450

450

450

450

450

450

450

450

450

920

Deferred rent, less current portion

-

-

0

0

0

170

-

-

-

0

142

144

145

146

147

148

148

148

149

148

148

147

147

145

144

143

141

139

137

135

133

130

127

124

121

118

115

Lease liability

392

421

449

476

502

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total long-term liabilities

392

421

449

476

502

170

0

0

1

2

146

147

149

151

153

154

180

243

305

367

427

488

505

4,351

4,359

593

591

590

588

587

585

583

580

578

576

573

3,763

TOTAL LIABILITIES

3,443

3,191

3,427

3,150

2,701

1,793

2,660

2,289

2,109

2,117

2,278

1,736

1,548

1,784

1,579

1,548

2,993

5,946

5,781

6,206

6,323

6,721

5,843

8,429

8,767

5,116

5,221

6,681

7,181

1,319

1,322

1,218

1,087

-

-

-

-

COMMITMENTS AND CONTINGENCIES (Note 7)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

STOCKHOLDERS' EQUITY:
Series C preferred stock: 215 issued and outstanding as of March 31, 2020 and December 31, 2019

-

-

-

-

-

-

-

0

637

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.00001 par value; 80,000,000 shares authorized; 9,396,015 and 9,386,689 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Additional paid-in capital

119,736

119,592

119,384

119,234

109,267

108,323

107,126

95,452

94,640

94,107

87,863

87,664

87,427

83,461

75,918

75,744

66,358

66,256

66,237

66,072

66,000

65,809

65,641

53,548

53,275

52,759

51,536

51,239

50,861

50,435

47,186

46,699

41,398

40,961

35,411

35,013

24,178

Accumulated deficit

-115,638

-111,681

-108,301

-104,397

-101,209

-97,588

-93,760

-90,745

-87,825

-84,349

-80,270

-76,799

-73,678

-70,787

-68,201

-65,915

-63,782

-64,606

-65,557

-63,699

-61,412

-59,111

-55,764

-56,088

-

-51,059

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54,002

-

47,111

45,795

43,731

40,277

38,120

36,068

33,837

31,480

29,514

27,605

24,045

Total stockholders' equity

5,245

9,059

12,231

15,985

9,846

13,260

16,880

4,706

7,452

10,754

7,592

10,864

13,748

13,539

7,716

9,829

2,576

1,649

680

2,373

4,588

6,697

9,876

-2,540

-727

1,699

4,426

5,443

7,130

10,158

9,066

10,631

7,561

9,481

5,897

7,408

133

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

8,689

12,250

15,658

19,135

12,548

15,054

19,540

6,996

9,561

12,871

9,871

12,601

15,297

15,324

9,296

11,377

5,569

7,596

6,461

8,580

10,911

13,419

15,719

5,888

8,040

6,815

9,647

12,125

14,311

11,478

10,389

11,850

8,648

10,563

6,994

8,431

4,802

Series B Preferred Stock [Member]
Preferred Stock Value

-

-

-

-

-

-

-

-

-

995

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series C Preferred Stock [Member]
Series C preferred stock: 215 issued and outstanding as of March 31, 2020 and December 31, 2019

1,148

1,148

1,148

1,148

1,789

2,526

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-